Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study

Pharmacotherapy
Amy Barton PaiHarold J Manley

Abstract

To investigate the impact of a pharmaceutical care program managed by clinical pharmacists on drug use, drug costs, hospitalization rates, and drug-related problems (DRPs) in ambulatory patients undergoing hemodialysis. Prospective, randomized, controlled, longitudinal, 2-year pilot study. Nonprofit university-affiliated dialysis clinic. One hundred four patients older than 18 years with end-stage renal disease (ESRD) who were undergoing a stable hemodialysis regimen for at least 3 months. Patients were randomly assigned to receive either pharmaceutical care, consisting of one-on-one care, with in-depth drug therapy reviews conducted by a clinical pharmacist (57 patients), or standard of care, consisting of brief drug therapy reviews conducted by a nurse (47 patients). Baseline data on demographic and clinical characteristics were collected. Mean numbers of concomitant drugs, drug costs, hospitalization rates, and lengths of stay were compared between the groups. In the pharmaceutical care group, DRPs were identified and recorded. Baseline age, length of time receiving hemodialysis, and etiology of ESRD were not significantly different between the groups. Mean number of concomitant drugs at baseline was similar between the grou...Continue Reading

References

Mar 1, 1994·The Annals of Pharmacotherapy·B KaplanF J Ascione
Apr 12, 2001·Journal of the American Pharmaceutical Association : APhA·F R Ernst, A J Grizzle
Jan 29, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Harold J ManleyRichard S Muther
Dec 24, 2003·BMC Nephrology·Harold J ManleyRichard S Muther

❮ Previous
Next ❯

Citations

Mar 28, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Norkasihan IbrahimYogini Jani
Apr 28, 2012·International Journal of Clinical Pharmacy·Teresa M SalgadoFernando Fernandez-Llimos
Jul 2, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Teresa M SalgadoFernando Fernandez-Llimos
Jul 27, 2011·Current Opinion in Nephrology and Hypertension·Nancy A Mason
Oct 1, 2013·Current Opinion in Nephrology and Hypertension·Wendy L St PeterUptal D Patel
Nov 6, 2013·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Tomoya TachiHitomi Teramachi
May 3, 2014·European Journal of Clinical Pharmacology·Benjamin J BasgerTimothy F Chen
Aug 20, 2014·International Journal of Clinical Pharmacy·Aurelio Cabello-MurielCarles Iniesta-Navalón
Jun 13, 2015·Journal of the American Pharmacists Association : JAPhA·Wendy M ParkerKatie E Cardone
Jan 26, 2010·Journal of the American Pharmacists Association : JAPhA·L Douglas Ried
Aug 27, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Harold J Manley, Amy Barton-Pai
Apr 20, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Eric D WeinhandlWendy L St Peter
Jan 8, 2016·International Journal of Clinical Pharmacy·Iga PawłowskaNatalia Krzyżaniak
Jun 20, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Bryan Kestenbaum
Apr 18, 2012·Clinical Transplantation·Jennifer J HarrisonLianne G Singer
Mar 20, 2013·Basic & Clinical Pharmacology & Toxicology·Trine Graabaek, Lene Juel Kjeldsen
Aug 24, 2010·Advances in Chronic Kidney Disease·Katie E CardoneHarold J Manley
Jun 16, 2015·Seminars in Dialysis·Renee Garrick, Rishikesh Morey
Sep 18, 2015·Frontiers in Public Health·Kyriakos SouliotisYiannis Tountas
Oct 28, 2016·Journal of Clinical Pharmacy and Therapeutics·M B HilscherJ Talwalkar
Nov 5, 2016·Néphrologie & thérapeutique·Stéphanie BelaicheUNKNOWN réseau Néphronor
Mar 24, 2017·Population Health Management·Priya RamarBjorg Thorsteinsdottir
Aug 23, 2017·International Journal of Clinical Pharmacy·Bih Yee ChiaPaik Shia Lim
Dec 22, 2017·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Uday Venkat MatetiDharshan Rangaswamy
Jan 3, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Laura C PlantingaBernard G Jaar
Jun 13, 2018·American Journal of Nephrology·Simit Doshi, Jay B Wish
Jul 31, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Dennis K Helling, Samuel G Johnson
Jun 20, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Chanel F WhittakerJeffrey C Fink
May 9, 2014·Journal of the American Society of Nephrology : JASN·Raymond M Hakim, Allan J Collins
Mar 25, 2019·Journal of Clinical Medicine·Wubshet H TesfayeBarbara C Wimmer
Aug 31, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Amy Barton PaiUNKNOWN Dialysis Advisory Group of American Society of Nephrology
Oct 5, 2017·The Cochrane Database of Systematic Reviews·Hanan KhalilAnthony J Avery
May 20, 2020·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Christopher CoddAmy Barton Pai
Dec 8, 2017·International Journal of Clinical Pharmacy·Saurav GhimireSyed Tabish R Zaidi
Oct 5, 2019·Clinical Kidney Journal·Kathrine Parker, Joanne Wong
Oct 5, 2018·Drugs & Aging·Laura K TriantafylidisJulie M Paik
Nov 1, 2016·European Journal of Hospital Pharmacy. Science and Practice·Markus MesserliMarkus L Lampert
Jul 31, 2017·Health Literacy Research and Practice·Genevra Galura, Amy Barton Pai
Nov 20, 2020·Seminars in Dialysis·Katie E Cardone, Wendy M Parker
Sep 14, 2020·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jill FramentHarold J Manley
Mar 23, 2021·International Journal of Clinical Pharmacy·Mais D ShqeiratBasima A Almomani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.